Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning-Eudract #: 2007-002420-15

Affiliations

• ¹ Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
• ² Department of Hematology/Oncology, University Hospital Halle, Halle (Saale), Germany.
• ³ Krukenberg Cancer Center, University Halle, Halle (Saale), Germany.
• ⁴ Leipzig Medical Center, Institute of Legal Medicine, University Leipzig, Leipzig, Germany.
• ⁵ Department for Operations Research and Statistics, Faculty of Organizational Sciences, University of Belgrade, Belgrade, Serbia.
• ⁶ Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany. vladan.vucinic@medizin.uni-leipzig.de.